Search for Clinical Trial Results
Primary Myelofibrosis - 26 Studies Found
Status | Study |
Completed |
Study Name: A Phase 2 Study With IPI-926 in Patients With Myelofibrosis Condition:
Date: 2011-06-09 Interventions: Drug: IPI-926 Single Arm study of oral IPI-926 at 160 mg, 130 mg or 110 mg daily, until progressive dise |
Completed |
Study Name: Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis Condition:
Date: 2011-01-18 |
Completed |
Study Name: Ph II Study of Azacitidine in Myelofibrosis Condition: Myelofibrosis Date: 2007-12-06 Interventions: Drug: Azacitidine 75 mg/m^2 subcutaneous daily for 7 days (every 4 week cycle) |
Recruiting |
Study Name: Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis Condition:
|
Active, not recruiting |
Study Name: Study of Ruxolitinib for Patients With Myelofibrosis (MF) Condition: Myelofibrosis Date: 2016-05-20 Interventions:
|
RECRUITING |
Study Name: Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis Condition: Primary Myelofibrosis Date: 2024-05-19 Interventions: Experimental |